1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study
(
- Contribution to journal › Article
- 2022
-
Mark
Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis
(
- Contribution to journal › Article
- 2017
-
Mark
Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis
(
- Contribution to journal › Article
- 2013
-
Mark
Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis.
(
- Contribution to journal › Article
- 2012
-
Mark
Splicosomal and serine and arginine-rich splicing factors as targets for TGF-β
(
- Contribution to journal › Article
- 2010
-
Mark
Interleukin-15 attenuates transforming growth factor-beta1-induced myofibroblast differentiation in human fetal lung fibroblasts.
(
- Contribution to journal › Article
- 2007
-
Mark
BAL fluid derived fibroblasts differ from biopsy derived fibroblasts in systemic sclerosis.
(
- Contribution to journal › Article
- 2006
-
Mark
Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma
(
- Contribution to journal › Article
- 2004
-
Mark
Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma
(
- Contribution to journal › Article
- 2002
-
Mark
The association between changes in skin echogenicity and the fibroblast production of biglycan and versican in systemic sclerosis
(
- Contribution to journal › Article